Bausch & Lomb stops ReNu contact solution shipments
WASHINGTON (Reuters) – Bausch & Lomb has stopped shipping
its ReNu brand contact lens solution after a number of people
using the product reported getting a serious eye infection, the
U.S. Food and Drug Administration said on Monday.
The FDA said that 109 cases of the rare but serious
infection that may cause loss of vision had been reported to
the Centers for Disease Control and Prevention (CDC) from 17
U.S. states. But the agency said during a conference call that
it was not aware of a link between the infection and specific
Bausch & Lomb’s stock was halted in afterhours trading on
Monday after falling more than 9 percent to $52.12 on Inet
electronic brokerage after the news. The stock had closed at
$57.44 on the New York Stock Exchange.
The FDA said it had completed cases on 30 reports. Of
those, 28 people wore soft contact lenses and 26 of them
reported using Bausch & Lomb’s ReNu brand in the month before
Five patients reported using other solutions in addition to
The infection, caused by the Fusarium fungus, may lead to
vision loss requiring corneal transplants, the FDA said.
The FDA and CDC are investigating the reported cases.